With these subscription figures, I think for retails investors who can apply 1 or 2 applications, its unnecessary to apply, wait for allotment, decide to sell or hold if allotted and spend time on listing day.chance of allotment very less when even L&T InfoTech like IPO is also being over subscribed in retail quota.
i have applied one lot through idirect.my account has been blocked.on going through bse site i find my application details had not been fed.what i have to do.please help me
529.2. Venkatram| Link| Bookmark|
July 22, 2016 3:50:40 PM
Top Contributor (300+ Posts, 100+ Likes)
for forms I dont know but the rest is just NSE + BSE numbers available in their website and mind you they may lag a little as this is sourced from more reliable and fast updating sources
looks like again the euphoria is back on this IPO and everyone is talking about all the positives like growth potential, niche player,second largest in India after Novozyme,and so on but some key negatives & risk points needs to be mentioned here...
Promoter defaulted 2 time in last 2 years for principal & interest 2014 was a big set back lost around 52 cr of profit Management received more than the limit set as remuneration in 2014-Auditors red flag Sinnar plant was closed due to temporary licence suspension in 2006 Promoter Vasant Rathi will get get around 190cr (150 from selling and 40cr from debt that he gave to one of the subsidiary) out of 400cr issue size Conflict of interest with one of the subsidiary (Advance vital enzymes ltd) significant dependence on us subsidiaries (54%) no long term agreement with supplier or customer..everyhthing is quote based trademark not registered related party transcation with Cal-India does not look to be a clean sign they have 20cr of contigent liability Interestingly Kotak entity is a share seller in offer and also the same entity is in the anchor investor list